Sale on Ophthalmic Equipment - Starting from 16 November!
Labcorp has agreed to buy Millennium Health, a speciality laboratory that offers urine and oral fluid drug testing, in the third takeover Labcorp has announced in eight days.
Labcorp has agreed to buy Millennium Health, an accredited speciality laboratory. Labcorp announced the Millennium Health buyout on Friday. The deal would add drug testing services to Labcorp's offering. The companies did not disclose financial terms, and the deal has not yet closed.
Millennium supplies tests that help clinicians track prescription medicines and illicit drugs in their patients. Its tests check urine and oral fluid for traces of drug use.
The results can show recent use of prescription, over the counter and illicit drugs. They can also flag drug use that may cause drug interactions.
Urine tests rely on mass spectrometry to detect drugs. Millennium also offers oral fluid testing as an alternative. Clinicians can observe a patient providing an oral fluid sample, which reduces the chance of tampering. The method also suits patients who cannot give a urine sample.
Labcorp plans to fold the tests into its wider range once the takeover closes. It says Millennium customers will gain from its larger test menu and its network of patient service centres.
Andrea Throop, head of toxicology at Labcorp, said in a statement that "we have an opportunity to make a greater impact on people living with chronic pain, mental health conditions and substance use disorders."
The Labcorp Millennium Health buyout is the third takeover the company has disclosed in eight days. The run began on 15 October. Labcorp said it would buy laboratory testing businesses owned by BioReference Health, a subsidiary of Opko Health, for $722 million.
A few days after that, it reached terms to take over the prenatal health testing unit of Myriad Genetics for $210 million. All three agreements came within the same month.
Labcorp has pursued growth through acquisitions for years. It has bought hospital testing businesses to widen its geographic reach and speciality laboratories to broaden its test menu.
Once complete, the Labcorp Millennium Health buyout would put toxicology and drug monitoring tests inside one of the largest laboratory networks. Medigear.uk follows the Labcorp Millennium Health buyout and the wider consolidation of laboratory services.
Source: MedTech Dive
Tell us the model and destination — our sourcing team will respond within one business day.

The Zimmer Monogram robot is now with US regulators. Zimmer Biomet has filed a 510(k) submission for…

The Abbott Encantor trial has begun. Abbott said on Thursday that it has started the VOYAGER CE clin…

Johnson & Johnson (J&J) said on Thursday that a Houston hospital will be the first to instal…
Approvals, trials, recalls and market moves — the essentials for procurement and clinical teams.